We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Commentary · March 12, 2021

Effect of Previous SARS-CoV-2 Infection on Humoral and T-Cell Responses to Single-Dose BNT162b2 Vaccine

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Effect of Previous SARS-CoV-2 Infection on Humoral and T-Cell Responses to Single-Dose BNT162b2 Vaccine
Lancet 2021 Feb 25;[EPub Ahead of Print], M Prendecki, C Clarke, J Brown, A Cox, S Gleeson, M Guckian, P Randell, AD Pria, L Lightstone, XN Xu, W Barclay, SP McAdoo, P Kelleher, M Willicombe

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading